Emergency use authorisation nod for Sputnik Light vaccine

The subject expert panel on vaccines has recommended the drug regulator to grant emergency use authorisation (EUA) to Russia’s Sputnik Light single-dose vaccine, sources said on Friday.

Sputnik Light is developed by Russia’s Gamaleya Center, built on a human adenovirus vector platform. In October last year, the government had approved the export of Sputnik Light, manufactured in India by Hetero Biopharma Limited.

The Sputnik is the same as component-1 of the Russian Sputnik V vaccine that has been used in India’s vaccination drive. India has administered close to 12 lakh doses of Sputnik V during the adult vaccination drive.

The company had earlier said that the single-shot vaccine has demonstrated 70 per cent efficacy against infection by the Delta variant.